Will Rocket Lab USA, Inc. (RKLB) hit (HIGH) $104 in July?

Rocket Lab stock has already traded at $104 this week. That single fact is the most important data point for this contract — you're not asking whether RKLB can reach a distant price target, you're asking whether a stock that just touched $104 can touch it again before July ends. The $104 level sits comfortably within RKLB's established recent trading range, with a 52-week band stretching from the low $30s to over $150. A stock that has demonstrated the volatility to trade between $95 and $104 in a single session is structurally capable of revisiting the upper end of that range repeatedly within a month-long window. This is less a directional valuation call and more a short-dated volatility question on a high-beta space stock. The fundamental backdrop supports the bull case. Wall Street analysts rate Rocket Lab USA overwhelmingly Buy, with one-year price targets clustered in the $103-$112 range and high-end targets stretching from $126 to $150. Bank of America, Citizens, Roth Capital, and Craig-Hallum have all raised Rocket Lab price targets recently, explicitly citing the $8 billion Iridium acquisition as transforming RKLB into a vertically integrated space platform rather than just a launch provider. That upgrade cycle creates positive newsflow that sustains buying pressure and supports revisiting recent highs. The Iridium acquisition narrative is the specific catalyst that differentiates the current RKLB story from prior trading periods. Analysts describing Rocket Lab as a potential SpaceX Starlink challenger — a "space powerhouse" rather than a niche small-launch provider — repositions the stock's valuation ceiling in ways that make $104 look like a base case rather than an aspirational target. Bottom line: RKLB hitting $104 in July requires the stock to do something it literally did this week. Watch for any additional analyst upgrades or Iridium integration updates as the catalysts most likely to sustain buying momentum through the month — and watch broader risk appetite in high-growth tech as the macro variable that most directly affects whether RKLB's beta works for or against this contract.